Rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab.

The article presents two case studies showing rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab. The first case is about a 78 year old woman who reported a one month history of decreased visual acuity in the right eye. The second case study is about a 91 year old man with a five month history of visual decrease.